⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for A Study of Tarceva (Erlotinib) and Standard of Care Chemotherapy in Patients With Advanced, Recurrent, or Metastatic Non-Small Cell Lung Cancer (NSCLC)

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: A Study of Tarceva (Erlotinib) and Standard of Care Chemotherapy in Patients With Advanced, Recurrent, or Metastatic Non-Small Cell Lung Cancer (NSCLC)

Official Title: An Open-label, Randomized Study to Evaluate the Effect of Tarceva, Compared With Alimta (Pemetrexed) or Taxotere (Docetaxel),on Survival in Patients With Advanced, Recurrent or Metastatic Non-small Cell Lung Cancer Who Have Experienced Disease Progression During Platinum-based Chemotherapy

Study ID: NCT00556322

Study Description

Brief Summary: This 2 arm study will evaluate the efficacy, safety, and pharmacokinetics of Tarceva and that of standard of care chemotherapy in patients with advanced, recurrent, or metastatic NSCLC experiencing disease progression after failure of platinum-based chemotherapy.Eligible patients will be randomized to receive either Tarceva 150mg po daily, or comparator (either Alimta 500mg/m2 every 3 weeks, or Taxotere 75mg/m2 every 3 weeks). The anticipated time on study treatment is until disease progression ,and the target sample size is 500+ individuals.

Detailed Description:

Keywords

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

, St. Leonards, New South Wales, Australia

, Waratah, New South Wales, Australia

, Adelaide, South Australia, Australia

, East Bentleigh, Victoria, Australia

, Fitzroy, Victoria, Australia

, Geelong, Victoria, Australia

, Melbourne, Victoria, Australia

, Innsbruck, , Austria

, Klagenfurt, , Austria

, Wien, , Austria

, Wien, , Austria

, Antwerpen, , Belgium

, Winnipeg, Manitoba, Canada

, Oshawa, Ontario, Canada

, Sault Ste Marie, Ontario, Canada

, Toronto, Ontario, Canada

, Laval, Quebec, Canada

, Montreal, Quebec, Canada

, Santiago, , Chile

, Beijing, , China

, Guangzhou, , China

, Guangzhou, , China

, Shanghai, , China

, Ceské Budejovice, , Czech Republic

, Olomouc, , Czech Republic

, Plzen, , Czech Republic

, Herlev, , Denmark

, Odense, , Denmark

, Bayonne, , France

, Brest, , France

, Clermont-ferrand, , France

, Dijon, , France

, Le Mans, , France

, Lille, , France

, Limoges, , France

, Paris, , France

, PAU, , France

, Toulouse, , France

, Vandoeuvre-les-nancy, , France

, Bad Berka, , Germany

, Bochum, , Germany

, Halle (Saale), , Germany

, Herne, , Germany

, Neuruppin, , Germany

, Villingen-Schwenningen, , Germany

, Athens, , Greece

, Athens, , Greece

, Heraklion, , Greece

, Budapest, , Hungary

, Budapest, , Hungary

, Deszk, , Hungary

, Nyíregyháza, , Hungary

, Pecs, , Hungary

, Szombathely, , Hungary

, Torokbalint, , Hungary

, Bologna, Emilia-Romagna, Italy

, Roma, Lazio, Italy

, Ancona, Marche, Italy

, Daegu, , Korea, Republic of

, Seoul, , Korea, Republic of

, Seoul, , Korea, Republic of

, Seoul, , Korea, Republic of

, Seoul, , Korea, Republic of

, Seoul, , Korea, Republic of

, Suwon, , Korea, Republic of

, Kaunas, , Lithuania

, Klaipeda, , Lithuania

, Vilnius, , Lithuania

, Kuala Lumpur, , Malaysia

, Penang, , Malaysia

, Auckland, , New Zealand

, Christchurch, , New Zealand

, Lodz, , Poland

, Lodz, , Poland

, Otwock, , Poland

, Bucuresti, , Romania

, Cluj Napoca, , Romania

, Iasi, , Romania

, Timisoara, , Romania

, Arkhangelsk, , Russian Federation

, Balashikha, , Russian Federation

, Chelyabinsk, , Russian Federation

, Kazan, , Russian Federation

, Kazan, , Russian Federation

, Kirov, , Russian Federation

, Krasnodar, , Russian Federation

, Krasnodar, , Russian Federation

, Kuzmolovo, , Russian Federation

, Moscow, , Russian Federation

, Moscow, , Russian Federation

, Moscow, , Russian Federation

, Moscow, , Russian Federation

, Nizhny Novgorod, , Russian Federation

, Perm, , Russian Federation

, Smolensk, , Russian Federation

, Soshi, , Russian Federation

, St Petersburg, , Russian Federation

, St Petersburg, , Russian Federation

, St Petersburg, , Russian Federation

, St Petersburg, , Russian Federation

, Yaroslavl, , Russian Federation

, Banska Bystrica, , Slovakia

, Bratislava, , Slovakia

, Nitra, , Slovakia

, Poprad, , Slovakia

, Golnik, , Slovenia

, Ljubljana, , Slovenia

, Maribor, , Slovenia

, Durban, , South Africa

, Johannesburg, , South Africa

, Pretoria, , South Africa

, Oviedo, Asturias, Spain

, Santander, Cantabria, Spain

, La Coruña, , Spain

, Zaragoza, , Spain

, Kharkov, , Ukraine

, Uzhgorod, , Ukraine

, Zaporozhye, , Ukraine

, Chelmsford, , United Kingdom

, Dundee, , United Kingdom

, Leicester, , United Kingdom

, Plymouth, , United Kingdom

, Caracas, , Venezuela

Contact Details

Name: Clinical Trials

Affiliation: Hoffmann-La Roche

Role: STUDY_DIRECTOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: